More recently, Arkadir et al. (2019) reported an enlarged area of hyperechogenicity also in the substantia nigra of asymptomatic GBA1 carriers and GD patients without PD, with respect to healthy controls. This evidence concerns the gene GBA1 and Parkinson disease.